Neuexcell Therapeutics is a gene therapy company that provides neural repair technology. It offers in situ astrocyte-to-neuron (AtN) technology that uses adeno-associated viruses (AAV) as a vector to deliver neural transcription factors to specific regions. The company used its platform for neurodegenerative diseases.